Article
Recombination between the postulated CCD/MHE/MHS locus and RYR1 gene markers.
Clinical genetics - 1 Dec 1996
Fagerlund T H, Islander G, Ranklev-Twetman E, Berg K
Abstract excerpt
Malignant hyperthermia (MH) susceptibility is considered a subclinical myopathy or a pharmacogenetic trait, and is believed to be closely associated with central core disease (CCD). Data support the notion that MH susceptibility is heterogeneous, with the ryanodine receptor I (RYR1) locus on chromosome 19 being one locus harboring a gene that can cause MH susceptibility. The gene for CCD is believed to reside in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
